Prolonged SARS-CoV-2 T Cell Responses in a Vaccinated COVID-19-Naive Population.
Vassiliki C PitirigaMyrto-Sotiria PapamentzelopoulouKanella E KonstantinakouIrene V VasileiouAlexandros D KonstantinidisNatalia I SpyrouAthanassios TsakrisPublished in: Vaccines (2024)
Our findings suggest that cellular immunity following SARS-CoV-2 vaccination may endure for at least six months, even in the presence of declining or absent IgG antibody levels.